Skip to contentN
Neogenomics Inc
N
NEONeogenomics Inc Q1 2025 · 10-Q
Revenue$168.04M$168.04M+7.5% vs Q1 2024 Net Income-$25.92M-$25.92MN/M vs Q1 2024 EPS Diluted-$0.20-$0.20N/M vs Q1 2024 Gross Profit$73,246,000+11.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
Operating Cash Flow-$25,327,000N/M Free Cash Flowderived-$29,827,000N/M Margins · derivedGross margin43.6%+1.7 pt vs Q1 2024
Operating margin-16.6%+3.0 pt vs Q1 2024
Net margin-15.4%+1.9 pt vs Q1 2024
ended Mar 31, 2025 · filed Apr 29, 2025 · 29 d after period end